California to Offer Low-Cost State-Branded Insulin
California has launched a state-branded insulin program meant to lower costs for people with diabetes.
The whole archive, newest first
California has launched a state-branded insulin program meant to lower costs for people with diabetes.
A Consumer Reports investigation tested 23 popular protein powders and meal-replacement shakes and found many contained troubling amounts of lead.
A combination of enzalutamide and the hormone therapy leuprolide—already used for metastatic prostate cancer—appears to extend survival when given earlier to men whose cancer returned…
Chronic constipation affects over one in 10 people worldwide and commonly causes infrequent bowel movements, hard stools, and abdominal discomfort.
Grammy-winning R&B singer Michael D'Angelo Archer, known professionally as D'Angelo, died on October 14 at age 51 after a private battle with pancreatic cancer, his family announced.
A large observational study published October 15 in JAMA Network Open found that GLP-1 receptor agonists (GLP-1RAs)—drugs often prescribed for weight loss such as semaglutide and…
Baking soda has become a viral DIY skin-care ingredient, promoted on social platforms for brightening dark spots, evening tone, and clearing acne.
A new Mental Health America report, State of Mental Health in America 2025, finds nearly a quarter of U.S.
Four decades after the American Cancer Society launched National Breast Cancer Awareness Month, deaths from breast cancer have fallen by roughly 42%.
The FDA has approved a generic version of mifepristone — the 200 mg tablet used with misoprostol for medication abortion through 70 days’ gestation.
A recent study found that rectal bleeding in adults younger than 50 raises the odds of an early-onset colorectal cancer diagnosis by about 8.5 times, signaling the symptom should be…
Open enrollment for Medicare runs from October 15 through December 7, 2026. This annual window lets people 65 and older enroll in Medicare or change their current coverage, including…